fda tirzepatide approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Joi + Blokes Zepbound 2026:

After 12 months of treatment, patients in these studies lost an average of 10 to 15 percent of their body weight, making this one of the most effective doctor-prescribed options currently available

That introductory rate covers the initial physician evaluation, your treatment plan, a metabolic report, the medication itself, and shipping with cold packs

Not everyones body can take the same amount

It works particularly well for researchers on moderate-dose protocols who want multiple weeks of supply from a single vial without the larger commitment (and cost) of a 30 mg vial

Those following vegetarian or vegan diets are at particularly high risk